CytoDyn (CYDY) Accounts Payables (2011 - 2026)

CytoDyn's Accounts Payables history runs 16 years deep, the most recent figure standing at $13.5 million for Q1 2026.

• Quarterly Accounts Payables fell 10.9% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $13.5 million (down 10.9% YoY) and the FY2025 annual result came in at $14.7 million, down 50.3% from the prior year.
• Accounts Payables was $13.5 million for Q1 2026 at CytoDyn, down from $14.2 million in the prior quarter.
• Across five years, Accounts Payables topped out at $69.0 million in Q3 2022 and bottomed at $13.5 million in Q1 2026.
• A 5-year average of $41.7 million and a median of $62.1 million in 2024 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2022 — Accounts Payables climbed 15.86% — and 2024, when it tumbled 77.44%.
• CytoDyn's Accounts Payables stood at $67.2 million in 2022, then retreated by 7.25% to $62.3 million in 2023, then sank by 77.15% to $14.2 million in 2024, then gained by 0.01% to $14.2 million in 2025, then decreased by 5.38% to $13.5 million in 2026.
• Business Quant data shows CYDY's Accounts Payables at $13.5 million in Q1 2026, $14.2 million in Q4 2025, and $14.2 million in Q3 2025.